The eighth phase of the Central Asia Drug Action Programme (CADAP 8) was officially launched on October 7, 2026, in Bishkek, Kyrgyzstan. The event took place at the Hyatt Regency and included representatives from the five Central Asian nations—Kazakhstan, Kyrgyzstan, Tajikistan, Turkmenistan, and Uzbekistan—alongside EU diplomats, international experts, and members of civil society.
Co-funded by the European Union, CADAP 8 will be implemented by a consortium led by the Fundación Internacional y para Iberoamérica de Administración y Políticas Públicas (FIAP) from Spain, in collaboration with CIVIPOL from France and the United Nations Office on Drugs and Crime (UNODC).
The launch featured speeches from several dignitaries, including H.E. Bolot Otunbaev, Ambassador at Large of the Kyrgyz Republic; H.E. Rémi Duflot, the EU Ambassador to Kyrgyzstan; H.E. Luis Francisco Martínez Montes, Ambassador of Spain; H.E. Nicolas Faye, Ambassador of France; Mr. Oliver Stolpe, UNODC Regional Representative; and Mr. Francisco Tierraseca, Director of FIAP.
CADAP 8 will focus on two main components:
- Component 1: Supply Reduction — This aspect aims to bolster Central Asian law enforcement and national agencies in combating illicit drug trafficking.
- Component 2: Demand Reduction — This will address drug consumption, improve health and prevention frameworks, and enhance rehabilitation efforts throughout the region.
CADAP symbolizes the enduring partnership between the European Union and Central Asian countries, emphasizing the need for evidence-based drug policies, adherence to human rights, and collaborative efforts to enhance regional security.
